Successful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis.

MLA

Oke, Anuoluwapo R., et al. “Successful Use of Adalimumab in Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis.” Rheumatology Advances in Practice, vol. 2, no. 1, Jan. 2018, p. rky001. EBSCOhost, https://doi.org/10.1093/rap/rky001.

APA

Oke, A. R., Wheater, M., Karydis, I., & Wallis, D. (2018). Successful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis. Rheumatology Advances in Practice, 2(1), rky001. https://doi.org/10.1093/rap/rky001

Chicago

Oke, Anuoluwapo R, Matthew Wheater, Ioannis Karydis, and Dinny Wallis. 2018. “Successful Use of Adalimumab in Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis.” Rheumatology Advances in Practice 2 (1): rky001. doi:10.1093/rap/rky001.